Lexaria Bioscience (LEXX.NASDAQ) (LEXX.CSE) $11 million financing supports R&D program targeting high blood pressure and SARS-CoV-2 infection
VANCOUVER, BC – Lexaria Bioscience’s (LEXX.NASDAQ) (LEXX.CSE) drug delivery technology, DehydraTECHTM improves the “bioavailability” of pharmaceutical ingredients. “Bioavailability is the rate and extent
[...]